T. Hosoya, Y. Ogawa, H. Hashimoto, T. Ohashi, R. Sakamoto. Comparison of topiroxostat and allopurinol in Japanese hyperuricemic patients with or without gout: A phase 3, multicentre, randomized, double-blind, double-dummy, active-controlled, parallel-group study. Journal of Clinical Pharmacy and Therapeutics. 2016. 41. 3. 290-297
T. Hosoya, T. Sasaki, H. Hashimoto, R. Sakamoto, T. Ohashi. Clinical efficacy and safety of topiroxostat in Japanese male hyperuricemic patients with or without gout: An exploratory, phase 2a, multicentre, randomized, double-blind, placebo-controlled study. Journal of Clinical Pharmacy and Therapeutics. 2016. 41. 3. 298-305
Shuichiro Yamanaka, Yoichi Miyazaki, Kenji Kasai, Shu-Ichi Ikeda, Sari Kiuru-Enari, Tatsuo Hosoya. Hereditary renal amyloidosis caused by a heterozygous G654A gelsolin mutation: A report of two cases. Clinical Kidney Journal. 2013. 6. 2. 189-193
Satoru Kuriyama, Yasushi Otsuka, Hiroyuki Ueda, Naoki Sugano, Takeo Yoshizawa, Taku Yamada, Tatsuo Hosoya. Augmented antihypertensive effect of a fixed combination formula of candesartan and hydrochlorothiazide combined with furosemide in a patient on peritoneal dialysis. Clinical and experimental nephrology. 2011. 15. 1. 175-8
Hideo Okonogi, Yasunori Utsunomiya, Yoichi Miyazaki, Kentarou Koike, Keita Hirano, Nobuo Tsuboi, Takahide Suzuki, Yoriko Hara, Makoto Ogura, Tatsuo Hosoya, et al. A predictive clinical grading system for immunoglobulin A nephropathy by combining proteinuria and estimated glomerular filtration rate. Nephron. Clinical practice. 2011. 118. 3. c292-300